scholarly journals Blood endothelin-1, t-PA, and PAI-1 in patients with cerebral thrombosis Evaluation of measurements at the acute and chronic phases, and the venous occlusion test.

Nosotchu ◽  
1996 ◽  
Vol 18 (3) ◽  
pp. 184-192
Author(s):  
Takeshi Ichino ◽  
Hiroshi Sugihara ◽  
Asahi Kamogawa ◽  
Nobuyoshi Narita ◽  
Tooru Shimizu
Keyword(s):  
Venous Occlusion ◽  
Cerebral Thrombosis ◽  
Endothelin 1 ◽  
Occlusion Test ◽  
Pai 1 ◽  
Venous Occlusion Test

Decreased fibrinolytic stimulation by a short-term venous occlusion test in patients with cerebrovascular disease

1995 ◽  
Vol 79 (4) ◽  
pp. 363-368 ◽  
Author(s):  
Bernhard Kempter ◽  
Alexander Peinemann ◽  
Oliver Biniasch ◽  
Roman L. Haberl
Keyword(s):  
Cerebrovascular Disease ◽  
Venous Occlusion ◽  
Short Term ◽  
Occlusion Test ◽  
Venous Occlusion Test

Study of the venous occlusion test in smokers

1990 ◽  
Vol 4 ◽  
pp. 65
Author(s):  
J.C. Gris ◽  
J.F. Schved ◽  
P. Martinez ◽  
A. Arnaud ◽  
N. Sanchez ◽  
...  
Keyword(s):  
Venous Occlusion ◽  
Occlusion Test ◽  
Venous Occlusion Test

Use of a Low-Molecular Weight Heparin (Enoxaparin) or of a Phenformin-like Substance (Moroxydine Chloride) in Primary Early Recurrent Aborters with an Impaired Fibrinolytic Capacity

1995 ◽  
Vol 73 (03) ◽  
pp. 362-367 ◽  
Author(s):  
Jean-Christophe Gris ◽  
Sylvie Neveu ◽  
Marie-Laure Tailland ◽  
Christophe Courtieu ◽  
Pierre Marès ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Venous Occlusion ◽  
Clot Lysis ◽  
Primary Study ◽  
Low Molecular Weight ◽  
Occlusion Test ◽  
Number Of Patients ◽  
Fibrinolytic Capacity ◽  
Venous Occlusion Test

SummaryAn impaired fibrinolytic capacity, defined as an insufficient venous occlusion-induced shortening of the plasma euglobulin clot lysis time, is a common feature in women suffering from primary early recurrent unexplained miscarriages (1,2). We investigated the therapeutic effect of a low-molecular-weight heparin and of a phenformin-like substance.In a prospective, randomized trial, 30 consecutive patients initially received either enoxaparin, 20 mg per day during one month, or moroxydine chloride, 1200 mg per day during one month. In case of fibrinolytic status normalization, they were treated during 6 months by the beneficial treatment which was planned to be continued during eventual pregnancies. Patients with hypofibrinolysis persistence received the alternative treatment during another month and a new evaluation was performed. No treatment was given when a persistent abnormal response to the venous occlusion test was evidenced. In case of positive response, the treatment was continued during 6 months. The primary study end-points consisted of any of the following: effect of the treatments on the fibrinolytic response; number of patients becoming pregnant during the 6 months following the last venous occlusion test; number of full-term pregnancies.Concerning the effects on the fibrinolytic system, 20 out of 29 women responded to the first or second-line enoxaparin treatment whereas only 1 woman out of 19 responded to moroxydine chloride (p=0.00002). Concerning the effects on fertility, responders to LMWH were more likely to initiate a new pregnancy than non-responders (16/20 vs 2/10, p=0.002). In patients conceiving, LMWH responders were more likely to obtain live births than nonresponders (13/16 vs. 0/2, p=0.02). The 9 women who had not responded to both treatments and the one who had responded to moroxydine chloride are still childless. Thirteen of the 20 previously childless women who had responded to enoxaparin had a successful pregnancy whilst taking the low-molecular weight heparin (p=0.0009).The low-molecular weight heparin enoxaparin was associated with successful pregnancies in patients with recurrent unexplained miscarriages associated with an impaired fibrinolytic capacity.

Studies on venous occlusion test (VO test) in collagen disease (especially, systemic lupus erythematodes).

1985 ◽  
Vol 16 (1) ◽  
pp. 56-58
Author(s):  
Hirochika MENJO ◽  
Toshihiko BANNO ◽  
Yoshika AMANO ◽  
Masatoshi YAMAMOTO ◽  
Takashi OGURI ◽  
...  
Keyword(s):  
Venous Occlusion ◽  
Lupus Erythematodes ◽  
Collagen Disease ◽  
Systemic Lupus ◽  
Systemic Lupus Erythematodes ◽  
Occlusion Test ◽  
Venous Occlusion Test

Simplification of a venous occlusion test

1991 ◽  
Vol 62 (1-2) ◽  
pp. 83-92 ◽  
Author(s):  
A. Mizuno ◽  
J. Isobe ◽  
K. Shima
Keyword(s):  
Venous Occlusion ◽  
Occlusion Test ◽  
Venous Occlusion Test

Venous occlusion test for the release of heparan sulfate from endothelium

1993 ◽  
Vol 72 (4) ◽  
pp. 359-361
Author(s):  
J. Hladovec ◽  
Z. Sommerová ◽  
I. Přerovský
Keyword(s):  
Heparan Sulfate ◽  
Venous Occlusion ◽  
Occlusion Test ◽  
Venous Occlusion Test
Sign in / Sign up

Export Citation Format

Share Document